Similar articles

• Shutting down a gene. Antisense drug wins approval.

  Stix G. Stix G. Sci Am. 1998 Nov;279(5):46, 50. doi: 10.1038/scientificamerican1198-46b. Sci Am. 1998. PMID: 9841380 No abstract available.
• Advances in antisense efficacy and delivery.

  Agrawal S, Akhtar S. Agrawal S, et al. Trends Biotechnol. 1995 Jun;13(6):197-9. doi: 10.1016/S0167-7799(00)88945-3. Trends Biotechnol. 1995. PMID: 7598842 No abstract available.
• Significant inhibitory effects of Hybridon's antisense compound on various HIV-1 replication steps in in vitro tests.

  [No authors listed] [No authors listed] AIDS Patient Care STDS. 1996 Dec;10(6):375-6. AIDS Patient Care STDS. 1996. PMID: 11361558 No abstract available.
• Oligonucleotides as inhibitors of human immunodeficiency virus.

  Field AK. Field AK. Curr Opin Mol Ther. 1999 Jun;1(3):323-31. Curr Opin Mol Ther. 1999. PMID: 11713797 Review.
• Treatment of AIDS with drugs targeted to inhibit different stages of the HIV life cycle.

  Sarin PS, Goldstein AL. Sarin PS, et al. Immunopharmacol Immunotoxicol. 1995 May;17(2):217-45. doi: 10.3109/08923979509019748. Immunopharmacol Immunotoxicol. 1995. PMID: 7650288 Review. No abstract available.